ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 972

$1.19M Total Retail Price of All Prescriptions

Rank: 47 out of 972

380 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

41% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 15,902 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,018 601 S3 1 6
LISINOPRIL 929 684 2 1
FUROSEMIDE 748 587 3 7
LEVOTHYROXINE SODIUM 536 410 4 3
POTASSIUM CHLORIDE 530 424 5 13
OMEPRAZOLE 527 324 6 5
RANITIDINE HCL 519 354 7 24
GABAPENTIN 475 321 8 14
AMLODIPINE BESYLATE 444 350 9 4
METFORMIN HCL 431 287 10 8
LOVASTATIN 369 267 11 22
CITALOPRAM HBR 320 265 12 19
METOPROLOL TARTRATE 312 262 13 9
CARVEDILOL 300 203 14 21
WARFARIN SODIUM 299 248 15 12
SIMVASTATIN 283 205 16 2
ISOSORBIDE MONONITRATE ER 243 210 17 43
ZOLPIDEM TARTRATE 234 163 18 23
PRAVASTATIN SODIUM 234 183 18 20
TRICOR 225 118 20 91
CYMBALTA 218 114 21 49
NEXIUM 213 110 22 30
CLOPIDOGREL 205 148 23 37
NAMENDA 200 196 24 38
DONEPEZIL HCL 199 191 25 26
ATENOLOL 183 143 26 18
HYDROCHLOROTHIAZIDE 182 145 27 10
ATORVASTATIN CALCIUM 172 136 28 11
GLYBURIDE 164 100 R 29 70
TRAMADOL HCL 162 120 30 15
AMITRIPTYLINE HCL 158 71 R 31 58
CIPROFLOXACIN HCL 156 134 32 63
PREDNISONE 155 131 33 40
AMOXICILLIN 153 109 34 121
BUSPIRONE HCL 149 115 35 105
MIRTAZAPINE 147 147 36 46
MELOXICAM 143 84 37 36
PLAVIX 140 99 38 55
METOPROLOL SUCCINATE 138 102 39 16
DIOVAN 136 91 40 48
QUETIAPINE FUMARATE 130 123 41 83
CYCLOBENZAPRINE HCL 130 74 R 41 53
PROAIR HFA 127 64 43 47
MEGESTROL ACETATE 124 116 R 44 195
CARISOPRODOL 123 12 R 45 110
ZETIA 119 28 46 79
LANTUS 114 112 47 44
JANUVIA 113 86 48 75
DIGOXIN 112 101 49 52
METHYLPREDNISOLONE 112 85 49 119
SINGULAIR 111 65 51 81
ALENDRONATE SODIUM 106 92 52 27
PROMETHAZINE HCL 105 38 R 53 154
NAPROXEN 105 71 53 71
ROPINIROLE HCL 101 56 55 72
PANTOPRAZOLE SODIUM 98 76 56 41
LUNESTA 97 71 57 232
NYSTATIN 96 72 58 156
FLUTICASONE PROPIONATE 93 67 59 31
AMOX TR-POTASSIUM CLAVULANATE 92 63 60 157
CLONIDINE HCL 92 67 60 57
IBUPROFEN 92 64 60 92
FENTANYL 92 47 S2 60 89
ADVAIR DISKUS 91 56 64 45
CLINDAMYCIN HCL 91 64 64 305
PREMARIN 89 70 R 66 153
LOSARTAN POTASSIUM 86 63 67 17
AZITHROMYCIN 83 64 68 42
TAMSULOSIN HCL 81 81 69 29
LEVETIRACETAM 81 35 69 111
THEOPHYLLINE ANHYDROUS 80 16 71 246
CRESTOR 80 47 71 33
LIDODERM 79 55 73 115
ESCITALOPRAM OXALATE 79 47 73 65
ENABLEX 78 43 75 204
RISPERIDONE 77 60 76 76
SPIRIVA 77 19 76 56
ALLOPURINOL 76 33 78 28
SULFASALAZINE 74 59 79 346
FENOFIBRATE 74 63 79 66
POLYETHYLENE GLYCOL 3350 72 48 81 67
SERTRALINE HCL 72 31 81 25
NIASPAN 71 15 83 144
LYRICA 71 30 83 113
GLIPIZIDE 71 57 83 59
XOPENEX HFA 71 21 83 269
HYDROCORTISONE 70 63 87 291
TRAMADOL HCL-ACETAMINOPHEN 70 50 87 155
OXYCODONE HCL-ACETAMINOPHEN 69 27 S2 89 106
NITROSTAT 69 28 89 223
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 57 91 109
KLOR-CON M20 66 43 92 78
FLUCONAZOLE 65 48 93 183
GEMFIBROZIL 65 52 93 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 40 95 32
PRENATAL PLUS 64 27 95 218
MONTELUKAST SODIUM 62 33 97 147
BUMETANIDE 61 55 98 173
FAMOTIDINE 61 37 98 73
ACETAMINOPHEN-CODEINE 61 49 S3 98 161
SPIRONOLACTONE 61 45 98 54
TRIAMCINOLONE ACETONIDE 59 46 102 134
FLUOXETINE HCL 58 19 103 60
OXYCODONE HCL 58 21 S2 103 112
DILTIAZEM 24HR CD 57 51 105 74
LOVAZA 57 16 105 136
INSULIN SYRINGE 56 34 107 84
METRONIDAZOLE 56 44 107 280
NASONEX 55 38 109 205
CARBIDOPA-LEVODOPA 55 54 109 87
PHENYTOIN SODIUM EXTENDED 54 34 111 140
TRAZODONE HCL 53 0 112 35
NOVOLIN R 53 52 112 185
ENALAPRIL MALEATE 52 48 114 50
HYDRALAZINE HCL 52 43 114 69
RAMIPRIL 52 36 114 101
LANTUS SOLOSTAR 50 31 117 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.